Press release
Cephalosporin Market Will be Valued at US$ 4,980 Million by 2023-End
Cephalosporin is a bactericidal β-lactam antibiotic, which is used to treat bacterial infections such as pneumonia, skin infections, strep throat, staph infections, tonsillitis, bronchitis, otitis media, and gonorrhea. Increase in incidence of the population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea drives the market growth.Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/3510?utm_source=openpr&utm_medium=ss
In addition, increase in R&D activities to develop highly efficient & safe drugs and an upsurge in use of combination therapies boost the growth of the market. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains impede the market growth.
Third-generation cephalosporin segment is expected to dominate the market throughout the analysis period, as these have a broader spectrum of activity. Fifth-generation cephalosporin is expected to register the highest CAGR of 7.6% during the forecast period.
According to Allied Market Research, the global cephalosporin market was valued at $3,136 million in 2016 and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023.
Make an Inquiry for purchasing this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3510?utm_source=openpr&utm_medium=ss
Major Players:
• Allergan Plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Lupin Limited
• Merck & Co. Inc.
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
Key Benefits:
• The study provides an in-depth analysis of the global cephalosporin market, with current trends and future estimations to elucidate imminent investment pockets.
• Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
Get a Special Discount on this Report @ https://www.alliedmarketresearch.com/checkout/873608?utm_source=openpr&utm_medium=ss
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cephalosporin Market Will be Valued at US$ 4,980 Million by 2023-End here
News-ID: 1507719 • Views: …
More Releases from Allied Market Research
Liability Insurance Market Global Opportunity Analysis and Industry Forecast, 20 …
Allied Market Research published a report, titled, "Liability Insurance Market by Coverage Type (General Liability Insurance, Professional Liability Insurance, Insurance for Directors and Officers), by Enterprise Size (Medium-sized Enterprises, Large Enterprises, Small Enterprises), by Application (Commercial, Personal): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global liability insurance industry generated $252.34 billion in 2021, and is expected to reach $432.81 billion by 2031, witnessing a CAGR…
Umbrella Insurance Market to Hit $170.7 Billion by 2031, Growing at 9.2% CAGR
Umbrella insurance is a form of casualty insurance designed to shield individuals from significant liability claims that surpass the coverage limits of their primary commercial general liability, business auto, and other business insurance policies. It offers a cost-effective solution for significantly increasing liability limits, providing added protection against catastrophic claims in today's unpredictable environment.
Request Sample Pages Now: https://www.alliedmarketresearch.com/request-sample/15130
Allied Market Research published a report, titled, "Umbrella Insurance Market Size by Coverage…
Bancassurance Market to Reach $1.8 Trillion by 2031, Growing at 7.4% CAGR
Allied Market Research published a report, titled, "Bancassurance Market by Insurance Type (Life Insurance, Non-Life Insurance), by Model Type (Pure Distributor Model, Strategic Alliance Model, Joint Venture Model, Financial Holding, Others), by End User (Personal, Business): Global Opportunity Analysis and Industry Forecast, 2021-2031" According to the report, the global bancassurance industry generated $901.5 billion in 2021, and is estimated to reach $1.8 trillion by 2031, witnessing a CAGR of 7.4%…
Lendtech Market to Reach $61.9 Billion by 2031, Growing at 23.2% CAGR
Allied Market Research published a report, titled, "LendTech Market by Component (Solution and Services), Deployment Mode (On-Premises and Cloud), Type (Consumer Lending and Business Lending), Organization Size (Large Enterprises and Small and Medium-sized Enterprises), and End User (Banks, Insurance Companies, Credit Unions and NBFCs) And Region (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031" According to the report, the global lendtech industry generated $8 billion…
More Releases for Cephalosporin
Cephalosporin API Market Growth and Restrain Factors Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cephalosporin API Market - (By Product Type (First Generation, Second Generation, Third Generation, Fourth Generation), By Formulation (Oral, Injection), By Consumer Type (Hospital Use, Clinic Use, Recovery Center)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Cephalosporin API Market is valued at US$ 1.70 billion…
Cephalosporin API Market in 2024 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cephalosporin API Market - (By Product Type (First Generation, Second Generation, Third Generation, Fourth Generation), By Formulation (Oral, Injection), By Consumer Type (Hospital Use, Clinic Use, Recovery Center)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Cephalosporin API Market is valued at US$ 1.70 billion…
Cephalosporin API Market in 2024 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cephalosporin API Market - (By Product Type (First Generation, Second Generation, Third Generation, Fourth Generation), By Formulation (Oral, Injection), By Consumer Type (Hospital Use, Clinic Use, Recovery Center)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Cephalosporin API Market is valued at US$ 1.70 billion…
Cephalosporin Market Overview, Growth And Forecast 2024-2033
The new report published by The Business Research Company, titled ""Cephalosporin Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the cephalosporin market size has grown steadily in recent years. It will grow from $17.04 billion in 2023 to…
Global Cephalosporin Market Size & Trends
According to a new market research report published by Global Market Estimates, the global cephalosporin market is expected to grow at a CAGR of 3.6% from 2023 to 2028.
Surgical procedures, whether elective or necessary, often require antibiotic prophylaxis to prevent post-operative infections. Cephalosporins are commonly used in such cases due to their effectiveness against a wide range of bacteria, reducing the risk of surgical site infections and complications.
Browse…
Cephalosporin Market 2023 Size, Share, Industry, Forecast to 2030
The Cephalosporin Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Cephalosporin market. This report explores all the key factors affecting the growth of the global Cephalosporin market, including demand-supply scenario, pricing…
